Indian pharma exports expected to touch USD 28 billion in FY 24: Pharmexcil Director General
New Delhi: Indian pharma exports may touch USD 28 billion during the current fiscal against USD 25.39 billion in FY 23, Udaya Bhaskar, Director General of Pharmaceuticals Export Promotion Council of India (Pharmexcil), a body under the Department of Commerce said.
Speaking to reporters he said during the current fiscal the exports cloaked over 10 per cent and 0.7 per cent growth in April and may respectively.
"In FY 23 we exported USD 25.39 billion worth of pharma goods with 3.25 per cent growth. When most commodities are not doing so well, India pharma made this and achieved this despite so many headwinds and global challenges," Bhaskar said replying to a query.
"I am ambitious that we may touch around USD 28 billion in FY 24. That is my expectation," he further said.
Justifying the target the official said the US market which has over 31 per cent share in over all exports last year has stabilised and it is positive sign indicating continuous growth.
Read also: More pharma products can be brought under quality improvement norms for export, says DGFT
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.